Back
Bellevue Life Sciences Acquisition Quote, Financials, Valuation and Earnings
Sponsored
BLAC
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
BLAC
Bellevue Life Sciences Acquisition
Last Price:
10.91
Seasonality Move:
0.77%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Bellevue Life Sciences Acquisition Price Quote
$10.91
+0.02 (+0%)
(Updated: September 20, 2024 at 6:25 AM ET)
Bellevue Life Sciences Acquisition Key Stats
Sell
32
Bellevue Life Sciences Acquisition (BLAC)
is a Sell
Day range:
$10.89 - $10.89
52-week range:
$10.39 - $11.60
Dividend yield:
0%
P/E ratio:
217.80
P/S ratio:
0.00
P/B ratio:
2.91%
Volume:
0
Avg. volume:
8.3K
1-year change:
4.81%
Market cap:
$44M
Revenue:
$0
EPS:
$-0.03
How Much Does Bellevue Life Sciences Acquisition Make?
Data Unavailable
Is Bellevue Life Sciences Acquisition Growing As A Company?
Data Unavailable
Bellevue Life Sciences Acquisition Stock Price Performance
-
Did Bellevue Life Sciences Acquisition Stock Go Up Last Month?
Bellevue Life Sciences Acquisition share price went up by 0.74% last month -
Did BLAC's Share Price Rise Over The Last Year?
BLAC share price rose by 4.81% over the past 1 year
What Is Bellevue Life Sciences Acquisition 52-Week High & Low?
-
What Is Bellevue Life Sciences Acquisition’s 52-Week High Share Price?
Bellevue Life Sciences Acquisition has traded as high as $11.60 over the past 52 weeks -
What Is Bellevue Life Sciences Acquisition’s 52-Week Low Share Price?
Bellevue Life Sciences Acquisition has traded as low as $10.39 over the past 52 weeks
Bellevue Life Sciences Acquisition Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Bellevue Life Sciences Acquisition?
-
How Much Debt Does Bellevue Life Sciences Acquisition Have?
Total long term debt quarterly is $0 -
How Much Cash Does Bellevue Life Sciences Acquisition Have?
Cash and short term investments quarterly total is $119.1K -
What Is Bellevue Life Sciences Acquisition’s Book Value Per Share?
Book value per share is 3.75
Is Bellevue Life Sciences Acquisition Cash Flow Positive?
-
What Is BLAC Cash Flow From Operations?
Cash flow from operations (TTM) is -$1.9M -
What Is Bellevue Life Sciences Acquisition’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$51.5M -
What Is Bellevue Life Sciences Acquisition’s Cash Flow From Investing?
Cash flow from investing (TTM) is $53.5M
Bellevue Life Sciences Acquisition Return On Invested Capital
Data Unavailable
Bellevue Life Sciences Acquisition Earnings Date & Stock Price
-
What Is Bellevue Life Sciences Acquisition's Stock Price Today?
A single share of BLAC can be purchased today for 10.89 -
What Is Bellevue Life Sciences Acquisition’s Stock Symbol?
Bellevue Life Sciences Acquisition trades on the nasdaq under the ticker symbol: BLAC -
When Is Bellevue Life Sciences Acquisition’s Next Earnings Date?
The next quarterly earnings date for Bellevue Life Sciences Acquisition is scheduled on November 7, 2024 -
When Is BLAC's next ex-dividend date?
Bellevue Life Sciences Acquisition's next ex-dividend date is September 20, 2024 -
How To Buy Bellevue Life Sciences Acquisition Stock?
You can buy Bellevue Life Sciences Acquisition shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Bellevue Life Sciences Acquisition Competitors
-
Who Are Bellevue Life Sciences Acquisition's Competitors?
Below is a list of companies who compete with Bellevue Life Sciences Acquisition or are related in some way:
Bellevue Life Sciences Acquisition Dividend Yield
-
What Is BLAC Dividend Yield?
Bellevue Life Sciences Acquisition’s dividend yield currently is 0% -
What Is Bellevue Life Sciences Acquisition’s Payout Ratio?
Bellevue Life Sciences Acquisition’s payout ratio is 0% -
When Did Bellevue Life Sciences Acquisition Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Bellevue Life Sciences Acquisition’s Dividend Per Share?
Bellevue Life Sciences Acquisition pays a dividend of $0.00 per share
Bellevue Life Sciences Acquisition Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |